1.Bou-Petit E, Hümmer S, Alarcon H, Slobodnyuk K, Cano-Galietero M, Fuentes P, Guijarro PJ, Muñoz MJ, Suarez-Cabrera L, Santamaria A, Estrada-Tejedor R, Borrell JI, Ramón Y Cajal S.. (2022) Overcoming Paradoxical Kinase Priming by a Novel MNK1 Inhibitor., 65 (8.0):[PMID:35417652][10.1021/acs.jmedchem.1c01941]
2.Zarrinkar, Patrick P PP and 15 more authors. 2009-10-01 AC220 is a uniquely potent and selective inhibitor of FLT3 for the treatment of acute myeloid leukemia (AML). [PMID:19654408]
3.Oyarzabal, Julen J and 12 more authors. 2010-09-23 Discovery of mitogen-activated protein kinase-interacting kinase 1 inhibitors by a comprehensive fragment-oriented virtual screening approach. [PMID:20722422]
4.Teo, Theodosia T and 11 more authors. 2015-10-20 An integrated approach for discovery of highly potent and selective Mnk inhibitors: Screening, synthesis and SAR analysis. [PMID:26408454]
5.Han, Wooseok W and 12 more authors. 2016-04-14 Discovery of a Selective and Potent Inhibitor of Mitogen-Activated Protein Kinase-Interacting Kinases 1 and 2 (MNK1/2) Utilizing Structure-Based Drug Design. [PMID:27002243]
6.Cherian, Joseph J and 24 more authors. 2016-04-14 Structure-Activity Relationship Studies of Mitogen Activated Protein Kinase Interacting Kinase (MNK) 1 and 2 and BCR-ABL1 Inhibitors Targeting Chronic Myeloid Leukemic Cells. [PMID:27011159]
7.Farag, Ahmed Karam AK and 5 more authors. 2017-12-01 Novel LCK/FMS inhibitors based on phenoxypyrimidine scaffold as potential treatment for inflammatory disorders. [PMID:29107425]
8.Reich, Siegfried H SH and 28 more authors. 2018-04-26 Structure-based Design of Pyridone-Aminal eFT508 Targeting Dysregulated Translation by Selective Mitogen-activated Protein Kinase Interacting Kinases 1 and 2 (MNK1/2) Inhibition. [PMID:29526098]
9.Yang, Haiyan H and 32 more authors. 2018-05-24 Optimization of Selective Mitogen-Activated Protein Kinase Interacting Kinases 1 and 2 Inhibitors for the Treatment of Blast Crisis Leukemia. [PMID:29683667]
10.Narayan, Satya S and 7 more authors. 2019-01-01 ASR352, A potent anticancer agent: Synthesis, preliminary SAR, and biological activities against colorectal cancer bulk, 5-fluorouracil/oxaliplatin resistant and stem cells. [PMID:30384048]
11.Yuan, Xinrui X and 5 more authors. 2019-04-01 Design, synthesis and biological evaluation of pyridone-aminal derivatives as MNK1/2 inhibitors. [PMID:30824167]
12.Abdelaziz, Ahmed M AM and 8 more authors. 2019-09-15 Synthesis and evaluation of 2'H-spiro[cyclohexane-1,3'-imidazo[1,5-a]pyridine]-1',5'-dione derivatives as Mnk inhibitors. [PMID:31362920]
13.Kwiatkowski, Jacek and 25 more authors. 2020-01-23 Stepwise Evolution of Fragment Hits against MAPK Interacting Kinases 1 and 2. [PMID:31910010]